LANCY(SZ:002612)2025-05-20 10:08Financial Performance - In Q1 2025, the company achieved total revenue of approximately 1.399 billion yuan, a year-on-year decrease of 7.77% [2] - Gross margin was 59.72%, an increase of 0.61 percentage points compared to the same period last year [2] - Net profit attributable to shareholders was approximately 95 million yuan, up 5.12% year-on-year; however, the net profit after deducting non-recurring gains and losses was about 73 million yuan, down 6.89% [2] - The net cash flow from operating activities was approximately 174 million yuan, a decrease of 23.43% year-on-year [2] - Basic earnings per share were 0.2153 yuan, an increase of 5.13% year-on-year; the weighted average return on net assets was 3.36% [2] Business Segment Performance - The medical beauty segment generated approximately 670 million yuan in revenue, a decrease of 9.22% year-on-year, with a gross profit of about 369 million yuan, down 8.58% [3] - The women's clothing segment achieved revenue of approximately 504 million yuan, a decrease of 5.74% year-on-year, with a gross profit of about 325 million yuan, up 5.52% [3] - The infant and child segment reported revenue of approximately 221 million yuan, down 8.52% year-on-year, with a gross profit margin of 62.28%, an increase of 1.78% [3] Brand Performance in Medical Aesthetics - Milan Baiyu reported Q1 2025 revenue of approximately 302.62 million yuan, down 8.74% year-on-year, with a gross margin of 54.62%, down 0.40% [4] - Jingfu Medical achieved revenue of approximately 125.20 million yuan, an increase of 1.13% year-on-year, with a gross margin of 46.17%, up 1.59% [4] - Hanchen Medical reported revenue of approximately 97.93 million yuan, down 1.43% year-on-year, with a gross margin of 54.47%, up 1.17% [4] Inventory and Sales Performance - As of Q1 2025, women's clothing inventory totaled approximately 646 million yuan, a decrease of 4.75% from the end of the previous year [6] - Online sales of women's clothing reached approximately 213 million yuan, a year-on-year increase of 14.31%, accounting for 42.62% of total sales, up 7.58 percentage points from the same period last year [6] Strategic Initiatives - The company plans to accelerate the acquisition of external medical beauty institutions, focusing on compliance and growth potential [5] - Emphasis on customer-centric strategies, enhancing communication between clients and medical professionals, and improving service delivery [5] - Continuous improvement of data governance capabilities to support business decisions and enhance operational efficiency [5]